Valuation: Stryker Corporation

Market Cap 127B 111B 103B 94.98B 180B 12,162B 183B 1,230B 483B 5,972B 477B 467B 20,625B P/E 2026 *
26.1x
P/E 2027 * 22.8x
Enterprise Value 136B 119B 110B 102B 192B 13,007B 196B 1,316B 516B 6,387B 510B 499B 22,058B EV / Sales 2026 *
4.98x
EV / Sales 2027 * 4.48x
Free-Float
94.62%
Yield 2026 *
1.09%
Yield 2027 * 1.17%
1 day+0.34%
1 week+1.36%
Current month+5.31%
1 month+5.86%
3 months-4.25%
6 months-6.62%
Current year-6.51%
1 week 317.38
Extreme 317.3801
335.79
1 month 295
Extreme 295
340
Current year 281.04
Extreme 281.04
389.55
1 year 281.04
Extreme 281.04
405.83
3 years 250.79
Extreme 250.79
406.7
5 years 191.18
Extreme 191.18
406.7
10 years 127.68
Extreme 127.6758
406.7
Manager TitleAgeSince
Chief Executive Officer 60 2012-09-30
Director of Finance/CFO 50 2025-03-31
President 49 2025-12-31
Director TitleAgeSince
Director/Board Member 82 1973-12-31
Director/Board Member 71 1983-12-31
Chairman 60 2014-07-21
Change 5-day change 1-year change 3-year change Capi.($)
+0.34%+1.36% - - 126B
+1.27%+1.63%+2.85%-1.24% 12.9B
0.00%+2.70%+47.11%+113.18% 8.97B
-2.84%-5.15%-50.08%-72.78% 3.98B
+1.52%+0.15%+22.38%+47.77% 2.7B
-5.07%-12.37%-19.07%-27.93% 1.74B
-1.19%-5.02%-7.21%-24.81% 1.61B
-0.77%+3.86%-60.57%-84.12% 1.49B
+1.94%+1.35%-22.86%-59.90% 1.48B
Average -0.53%+0.30%-10.93%-13.73% 4.36B
Weighted average by Cap. +0.27%+1.28%+4.34%+15.36%

Financials

2026 *2027 *
Net sales 27.27B 23.92B 22.15B 20.38B 38.55B 2,610B 39.3B 264B 104B 1,282B 102B 100B 4,426B 29.59B 25.95B 24.03B 22.11B 41.83B 2,832B 42.64B 286B 112B 1,391B 111B 109B 4,802B
Net income 4.84B 4.25B 3.94B 3.62B 6.85B 464B 6.98B 46.91B 18.4B 228B 18.19B 17.8B 786B 5.54B 4.86B 4.5B 4.14B 7.84B 531B 7.99B 53.68B 21.05B 261B 20.82B 20.36B 900B
Net Debt 8.83B 7.74B 7.17B 6.6B 12.48B 845B 12.72B 85.47B 33.52B 415B 33.15B 32.42B 1,433B 5.47B 4.79B 4.44B 4.09B 7.73B 523B 7.88B 52.93B 20.76B 257B 20.53B 20.08B 887B
Logo Stryker Corporation
Stryker Corporation is one of the world's leaders in designing, manufacturing and marketing medical equipment and devices in the fields of medical surgery, neurotechnology and orthopaedics. Net sales break down by family of products as follows: - surgical equipment and neurotechnology products (62.3%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipment, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (37.7%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2025, the group had 55 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (75.7%), Europe/Middle East/Africa (12.7%), Asia/Pacific (8.6%) and other (3%).
Employees
56,000
Date Price Change Volume
26-07-13 US$333.78 +1.01% 455
26-07-10 US$330.43 +0.72% 471
26-07-09 US$328.07 -0.08% 743
26-07-08 US$328.34 +0.45% 520
26-07-07 US$326.86 +0.17% 1,950
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
331.45USD
Average target price
385.92USD
Spread / Average Target
+16.43%

Quarterly revenue - Rate of surprise